SBIR-STTR Award

Stentless Semilunar Heart Valve Reconstruction
Award last edited on: 9/20/13

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$974,493
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Jack W Love

Company Information

Cardiomend LLC

2410 Fletcher Avenue Suite 101
Santa Barbara, CA 93105
   (805) 563-6070
   info@cardiomend.com
   www.cardiomend.com
Location: Multiple
Congr. District: 24
County: Santa Barbara

Phase I

Contract Number: 1R43HL061075-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$100,000
Worldwide, there is an unmet need for cost-effective treatment of valvular heart disease, especially in third world and lesser developed countries. The long-term objective of this project is to introduce a new and cost-effective paradigm for the treatment of aortic and pulmonic valvular heart disease that relies on valve reconstruction rather than replacement, and which is based on novel geometry, newly designed disposable instruments, and the use of autologous tissue. Surgical reconstruction is performed by an easily learned and reproducible method without stents, leaving the patient with only his or her own tissue and sutures. The concept has been articulated, prototypes have been made, animal experiments performed for proof of concept, regulatory approvals obtained, and patent protection initiated. Prior to clinical use, there are four specific aims to be accomplished: geometric optimization of a new unitary tissue pattern with computer assisted design (CAD) techniques, pulse duplicator and static load testing; development of a device for intraoperative testing of tissue thickness, tensile strength and isotropism; selection of the best method for cutting the tissue intraoperatively; and choosing the best material and manufacturing method for the disposable instruments.Proposed Commercial Application:The combination of an easily learned, reproducible method and inexpensive, disposable instruments for reconstruction of diseased aortic and pulmonic heart valves using lightly tanned autologous pericardium without stents has the potential for answering a worldwide need for more cost-effective treatment of valvular heart disease, thus making such treatment available to a greater patient population.

Thesaurus Terms:
aortic valve, consumable /disposable biomedical equipment, heart surgery, heart valve disorder, method development, surgery material /equipment autologous transplantation, biomedical equipment development, computer assisted patient care, computer simulation, heart rate, pericardium, revascularization surgery, tensile strength

Phase II

Contract Number: 2R44HL061075-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2000
(last award dollars: 2001)
Phase II Amount
$874,493

___(NOTE: Note: no official Abstract exists of this Phase II projects. Abstract is modified by idi from relevant Phase I data. The specific Phase II work statement and objectives may differ)___ Worldwide, there is an unmet need for cost-effective treatment of valvular heart disease, especially in third world and lesser developed countries. The long-term objective of this project is to introduce a new and cost-effective paradigm for the treatment of aortic and pulmonic valvular heart disease that relies on valve reconstruction rather than replacement, and which is based on novel geometry, newly designed disposable instruments, and the use of autologous tissue. Surgical reconstruction is performed by an easily learned and reproducible method without stents, leaving the patient with only his or her own tissue and sutures. The concept has been articulated, prototypes have been made, animal experiments performed for proof of concept, regulatory approvals obtained, and patent protection initiated. Prior to clinical use, there are four specific aims to be accomplished: geometric optimization of a new unitary tissue pattern with computer assisted design (CAD) techniques, pulse duplicator and static load testing; development of a device for intraoperative testing of tissue thickness, tensile strength and isotropism; selection of the best method for cutting the tissue intraoperatively; and choosing the best material and manufacturing method for the disposable instruments.Proposed Commercial Application:The combination of an easily learned, reproducible method and inexpensive, disposable instruments for reconstruction of diseased aortic and pulmonic heart valves using lightly tanned autologous pericardium without stents has the potential for answering a worldwide need for more cost-effective treatment of valvular heart disease, thus making such treatment available to a greater patient population.

Thesaurus Terms:
aortic valve, consumable /disposable biomedical equipment, heart surgery, heart valve disorder, method development, surgery material /equipment autologous transplantation, biomedical equipment development, computer assisted patient care, computer simulation, heart rate, pericardium, revascularization surgery, tensile strength